Skip to content
Search

Latest Stories

Alliance Healthcare UK appoints Paula Sutherland as sales director

Paula Sutherland is committed to further strengthening Alliance Healthcare’s partnerships with community pharmacies
Paula Sutherland - Alliance Healthcare UK Sales Director

 Paula Sutherlandis committed to further strengthening Alliance Healthcare’s partnerships with community pharmacies  

Alliance Healthcare UK has appointed Paula Sutherland as sales director to lead its sales teams in delivering products and services to community pharmacies.

In her new role, Paula will focus on ensuring that the company’s offerings align with the unique needs of pharmacies and their patients.


Since joining Alliance Healthcare in 2012, Paula has held various leadership roles that have focused on building strong relationships with community pharmacies, manufacturer partners, and hospital services.

Her extensive experience is expected to further strengthen the company's partnerships with community pharmacies.

Before joining Alliance Healthcare, Paula gained valuable experience in commercial roles within the fast-moving consumer goods sector, at companies such as Perrigo UK and global supply-chain logistics company CHEP.

Expressing her enthusiasm, Paula said: “I am delighted to step into this position at such an exciting time for Alliance Healthcare, and at such a pivotal moment for the sector.”

She highlighted the critical role pharmacists play in local communities, acknowledging the challenging circumstances they face.

Paula is committed to working closely with the company’s expert field team to enhance their support for pharmacy customers.

“By ensuring that community pharmacies are well-supported, we can create healthier communities and enhance the quality of care for all patients,” she added.

Marie Evans, managing director at Alliance Healthcare, praised Paula’s contributions, stating, “Paula has been an invaluable part of the Alliance Healthcare team, demonstrating exceptional leadership and dedication in every role she has undertaken.”

She further emphasised that pharmacy relationships are an integral part of their business, and Paula’s deep understanding of the pharmacy landscape and ability to foster strong partnerships makes her “the ideal person to lead our teams going forwards.”

More For You

Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less
Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less